INDIVIOR PLC (INDV) Stock Fundamental Analysis
USA - NASDAQ:INDV - GB00BN4HT335 - Common Stock
25.143 USD
+0.23 (+0.94%)
INDV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 192 industry peers in the Pharmaceuticals industry. INDV has only an average score on both its financial health and profitability. INDV has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year INDV was profitable.
INDV had a positive operating cash flow in the past year.
In multiple years INDV reported negative net income over the last 5 years.
In multiple years INDV reported negative operating cash flow during the last 5 years.
1.2 Ratios
INDV's Return On Assets of -4.00% is fine compared to the rest of the industry. INDV outperforms 73.44% of its industry peers.
With an excellent Return On Invested Capital value of 111.88%, INDV belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
INDV had an Average Return On Invested Capital over the past 3 years of 43.06%. This is significantly above the industry average of 15.41%.
The 3 year average ROIC (43.06%) for INDV is below the current ROIC(111.88%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4% | ||
| ROE | N/A | ||
| ROIC | 111.88% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
1.3 Margins
INDV's Profit Margin has declined in the last couple of years.
The Operating Margin of INDV (25.44%) is better than 92.19% of its industry peers.
INDV's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 83.98%, INDV belongs to the best of the industry, outperforming 88.54% of the companies in the same industry.
In the last couple of years the Gross Margin of INDV has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.44% | ||
| PM (TTM) | N/A | ||
| GM | 83.98% |
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), INDV is creating value.
Compared to 1 year ago, INDV has less shares outstanding
INDV has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, INDV has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.36 indicates that INDV is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.36, INDV is doing good in the industry, outperforming 70.83% of the companies in the same industry.
INDV has a debt to FCF ratio of 2.49. This is a good value and a sign of high solvency as INDV would need 2.49 years to pay back of all of its debts.
INDV has a better Debt to FCF ratio (2.49) than 91.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.49 | ||
| Altman-Z | 3.36 |
ROIC/WACC12.04
WACC9.29%
2.3 Liquidity
A Current Ratio of 0.88 indicates that INDV may have some problems paying its short term obligations.
The Current ratio of INDV (0.88) is worse than 85.94% of its industry peers.
INDV has a Quick Ratio of 0.88. This is a bad value and indicates that INDV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.72, INDV is not doing good in the industry: 85.42% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
The earnings per share for INDV have decreased strongly by -24.28% in the last year.
The earnings per share for INDV have been decreasing by -29.07% on average. This is quite bad
Looking at the last year, INDV shows a small growth in Revenue. The Revenue has grown by 4.34% in the last year.
Measured over the past years, INDV shows a decrease in Revenue. The Revenue has been decreasing by -4.53% on average per year.
EPS 1Y (TTM)-24.28%
EPS 3Y-29.07%
EPS 5YN/A
EPS Q2Q%15.91%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y-4.53%
Revenue growth 5YN/A
Sales Q2Q%1%
3.2 Future
Based on estimates for the next years, INDV will show a very negative growth in Earnings Per Share. The EPS will decrease by -15.65% on average per year.
Based on estimates for the next years, INDV will show a decrease in Revenue. The Revenue will decrease by -6.61% on average per year.
EPS Next Y8.11%
EPS Next 2Y-1.39%
EPS Next 3Y-10.28%
EPS Next 5Y-15.65%
Revenue Next Year3.53%
Revenue Next 2Y-2.92%
Revenue Next 3Y-9.06%
Revenue Next 5Y-6.61%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 14.37, the valuation of INDV can be described as correct.
Based on the Price/Earnings ratio, INDV is valued cheaper than 86.98% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.00. INDV is valued slightly cheaper when compared to this.
INDV is valuated correctly with a Price/Forward Earnings ratio of 14.77.
Based on the Price/Forward Earnings ratio, INDV is valued cheaply inside the industry as 82.29% of the companies are valued more expensively.
INDV is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.87, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.37 | ||
| Fwd PE | 14.77 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, INDV is valued cheaper than 97.40% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of INDV indicates a rather cheap valuation: INDV is cheaper than 83.33% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.77 | ||
| EV/EBITDA | 5.58 |
4.3 Compensation for Growth
INDV's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of INDV may justify a higher PE ratio.
INDV's earnings are expected to decrease with -10.28% in the coming years. This may justify a cheaper valuation.
PEG (NY)1.77
PEG (5Y)N/A
EPS Next 2Y-1.39%
EPS Next 3Y-10.28%
5. Dividend
5.1 Amount
INDV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:INDV (10/29/2025, 2:06:09 PM)
25.143
+0.23 (+0.94%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners94.68%
Inst Owner Change0.56%
Ins Owners3.79%
Ins Owner ChangeN/A
Market Cap3.14B
Revenue(TTM)1.06B
Net Income(TTM)-55000000
Analysts82.5
Price Target14.88 (-40.82%)
Short Float %5.01%
Short Ratio3.04
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.37 | ||
| Fwd PE | 14.77 | ||
| P/S | 1.52 | ||
| P/FCF | 23.77 | ||
| P/OCF | 18.9 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.58 |
EPS(TTM)1.75
EY6.96%
EPS(NY)1.7
Fwd EY6.77%
FCF(TTM)1.06
FCFY4.21%
OCF(TTM)1.33
OCFY5.29%
SpS16.51
BVpS-2.28
TBVpS-2.34
PEG (NY)1.77
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4% | ||
| ROE | N/A | ||
| ROCE | 141.62% | ||
| ROIC | 111.88% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 25.44% | ||
| PM (TTM) | N/A | ||
| GM | 83.98% | ||
| FCFM | 6.41% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)54.5%
ROCE(5y)38.6%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
F-Score5
Asset Turnover1.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.49 | ||
| Debt/EBITDA | 0.57 | ||
| Cap/Depr | 136% | ||
| Cap/Sales | 1.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.24% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 3.36 |
F-Score5
WACC9.29%
ROIC/WACC12.04
Cap/Depr(3y)163.83%
Cap/Depr(5y)132.28%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.28%
EPS 3Y-29.07%
EPS 5YN/A
EPS Q2Q%15.91%
EPS Next Y8.11%
EPS Next 2Y-1.39%
EPS Next 3Y-10.28%
EPS Next 5Y-15.65%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y-4.53%
Revenue growth 5YN/A
Sales Q2Q%1%
Revenue Next Year3.53%
Revenue Next 2Y-2.92%
Revenue Next 3Y-9.06%
Revenue Next 5Y-6.61%
EBIT growth 1Y103.89%
EBIT growth 3Y11.69%
EBIT growth 5Y7.28%
EBIT Next Year13.79%
EBIT Next 3Y10.08%
EBIT Next 5Y12.03%
FCF growth 1Y473.91%
FCF growth 3Y-74.97%
FCF growth 5Y-48.94%
OCF growth 1Y374.29%
OCF growth 3Y-53.28%
OCF growth 5Y-24.93%
INDIVIOR PLC / INDV FAQ
What is the fundamental rating for INDV stock?
ChartMill assigns a fundamental rating of 4 / 10 to INDV.
Can you provide the valuation status for INDIVIOR PLC?
ChartMill assigns a valuation rating of 6 / 10 to INDIVIOR PLC (INDV). This can be considered as Fairly Valued.
What is the profitability of INDV stock?
INDIVIOR PLC (INDV) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for INDV stock?
The Price/Earnings (PE) ratio for INDIVIOR PLC (INDV) is 14.37 and the Price/Book (PB) ratio is -11.01.
What is the financial health of INDIVIOR PLC (INDV) stock?
The financial health rating of INDIVIOR PLC (INDV) is 5 / 10.